Lexaria Bioscience
$1.04
24
+$0.17+20.08% Thursday 19:59
Statistics
Day High
1.05
Day Low
0.88
52W High
1.69
52W Low
0.46
Volume
613,935
Avg. Volume
178,137
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
14AprExpected
Expected EPS
-0.095
Actual EPS
N/A
Financials
-1,685.69%Profit Margin
Unprofitable1.41MRevenue
-23.8MNet Income
Analyst Ratings
$1.50Average Price Target
The highest estimate is 1.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LEXX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Aurora Cannabis
ACB
Mkt Cap280.01M
Canopy Growth
CGC
Mkt Cap418.51M
Tilray Brands
TLRY
Mkt Cap1.5B
Curaleaf
CURLF
Mkt Cap2.16B
Green Thumb Industries
GTBIF
Mkt Cap1.65B
About
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Show more...
CEO
Mr. Richard C. Christopher
Employees
7
Country
CA
ISIN
US52886N4060
Listings
0 Comments
Share your thoughts
FAQ
What is Lexaria Bioscience stock price today?▼
The current price of LEXX is $1.04 USD — it has increased by +20.08% in the past 24 hours. Watch Lexaria Bioscience stock price performance more closely on the chart.
What is Lexaria Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lexaria Bioscience stocks are traded under the ticker LEXX.
Is Lexaria Bioscience stock price growing?▼
LEXX stock has risen by +40.11% compared to the previous week, the month change is a +54.07% rise, over the last year Lexaria Bioscience has showed a -32.03% decrease.
When is the next Lexaria Bioscience earnings date?▼
Lexaria Bioscience is going to release the next earnings report on April 14, 2026.
What were Lexaria Bioscience earnings last quarter?▼
LEXX earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.13 USD resulting in a +23.08% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lexaria Bioscience revenue for the last year?▼
Lexaria Bioscience revenue for the last year amounts to 1.41M USD.
What is Lexaria Bioscience net income for the last year?▼
LEXX net income for the last year is -23.8M USD.
How many employees does Lexaria Bioscience have?▼
As of April 03, 2026, the company has 7 employees.
In which sector is Lexaria Bioscience located?▼
Lexaria Bioscience operates in the Health Care sector.
When did Lexaria Bioscience complete a stock split?▼
Lexaria Bioscience has not had any recent stock splits.
Where is Lexaria Bioscience headquartered?▼
Lexaria Bioscience is headquartered in Kelowna, CA.